UiPath, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A (P2AT34) Stock Price & Analysis

P2AT34 Stock Chart & Stats

R$9.16-R$0.04(-0.43%)

At close: Nov 12

Day’s Range: BRL 9.16 - BRL 9.30
52-Week Range: BRL 5.72 - BRL 13.44
Previous Close: BRL 9.20
Volume: N/A
Average Volume (3M): 1,680
Market Cap: BRL 38.64B
Enterprise Value: BRL 27.56B
Total Cash (Recent Filing): N/A
Total Debt (Recent Filing): N/A
Price to Earnings (P/E): 20391.8
Beta: -0.57
Next Earnings: Dec 03, 2026 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

UiPath, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A News

UiPath announces it is a launch partner for Google’s Gemini for healthcare

UiPath (PATH) announced it is a launch partner for Google Cloud’s (GOOGL) Gemini for healthcare. Using the UiPath MCP Server, organizations can connect Gemini to the automations and agents built

3d agoGOOG PATH

UiPath call volume above normal and directionally bullish

Bullish option flow detected in UiPath (PATH) with 15,879 calls trading, 1.6x expected, and implied vol increasing over 8 points to 64.37%. Mar-27 15 calls and 11/6 weekly 15 calls

1w agoPATH 9UV

Cboe data shows mixed options sentiment in UiPath with shares down 1.18%

Cboe data shows mixed options sentiment in UiPath (PATH), with shares down 16c near $13.01. Options volume relatively light with 14k contracts traded and calls leading puts for a put/call

1M agoPATH 9UV

UiPath announces Test Cloud availability on Oracle Marketplace

UiPath (PATH) announced that UiPath Test Cloud is now available on Oracle Marketplace. UiPath Test Cloud provides organizations with capabilities designed to help accelerate software testing with agentic, AI-powered capabilities

1M agoPATH 9UV

Buy/Sell: Wall Street’s top 10 stock calls this week

What has Wall Street been buzzing about this week? Here are the top 5 Buy calls and the top 5 Sell calls made by Wall Street’s best analysts during the

1M agoTGT WBD

UiPath joins NCQA AI Learning Collaborative

UiPath (PATH) announced its participation in the National Committee for Quality Assurance’s AI Learning Collaborative for Prior Authorization, an initiative designed to help healthcare organizations responsibly evaluate, implement and scale

1M agoPATH 9UV

Midday Fly By: Boeing secures $20B Strike Fighter deal, Conagra reports Q1 beat

The S&P was higher near noon after new U.S. economic data showed inflation slowed last month. Inflation-adjusted U.S. personal spending increased 0.6% month-on-month in August, the most since March 2025,

1M agoF BA

UiPath, Snowflake expand partnership with two-way integration

UiPath (PATH) announced an expansion of its partnership with Snowflake (SNOW). Building on last year’s integration of UiPath’s automation platform with Snowflake Cortex AI, the expanded partnership connects Snowflake’s governed

1M agoPATH SNOW

UiPath, BDO expand partnership to build agentic solution accelerators

UiPath (PATH) and BDO USA announced an expanded collaboration focused on building artificial intelligence and business orchestration solutions for priority enterprise functions. Together, UiPath and BDO will create agents that

1M agoPATH 9UV

Cboe data shows mixed options sentiment in UiPath with shares down 1.73%

Cboe data shows mixed options sentiment in UiPath (PATH), with shares down 22c near $12.24. Options volume relatively light with 28k contracts traded and calls leading puts for a put/call

1M agoPATH 9UV

UiPath Kept at Hold as Analyst Lowers Price Target to $14 Amid AI Promise but Core Growth Concerns

Kingsley Crane, an analyst from Canaccord Genuity, reiterated the Hold rating on UiPath. The associated price target was lowered to $14.00. Kingsley Crane has given his Hold rating due to

1M agoPATH 9UV

UiPath: Strategically Strong AI Automation Platform, But Valuation Leaves Risk‑Reward Balanced, Justifying Hold Rating

William Blair analyst Patrick McIlwee has maintained their neutral stance on PATH stock, giving a Hold rating today. Patrick McIlwee has given his Hold rating due to a combination of

1M agoPATH 9UV

Koji Ikeda Reiterates Sell on UiPath, Keeps $15 Price Target Amid Limited Visibility on Growth Acceleration

Analyst Koji Ikeda from Bank of America Securities maintained a Sell rating on UiPath and keeping the price target at $15.00. Koji Ikeda has given his Sell rating due to

1M agoPATH 9UV

UiPath Earns Hold Rating Despite Strong Results and Raised Guidance as Analyst Awaits Clearer AI-Driven Growth Acceleration

William Blair analyst Patrick McIlwee has reiterated their neutral stance on PATH stock, giving a Hold rating today. Patrick McIlwee has given his Hold rating due to a combination of

2M agoPATH 9UV

P2AT34 FAQ

What was UiPath, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A’s price range in the past 12 months?

UiPath, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A lowest stock price was R$5.72 and its highest was R$13.44 in the past 12 months.

What is UiPath, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A’s market cap?

UiPath, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A’s market cap is R$38.64B.

When is UiPath, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were UiPath, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A’s earnings last quarter?

UiPath, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A released its earnings results on Sep 03, 2026. The company reported R$0 earnings per share for the quarter.

Is UiPath, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does UiPath, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A pay dividends?

UiPath, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A does not currently pay dividends.

What is UiPath, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A’s EPS estimate?

UiPath, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does UiPath, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A have?

UiPath, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A has 456,464,700 shares outstanding.

What happened to UiPath, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A’s price movement after its last earnings report?

UiPath, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A reported an EPS of R$0 in its last earnings report. Following the earnings report the stock price went down -14.66%.

Which hedge fund is a major shareholder of UiPath, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A?

Currently, no hedge funds are holding shares in BR:P2AT34

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

UiPath, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A (P2AT34) Earnings & Revenues

Historic Earnings Reports

Technical Analysis

Overall Consensus

Indicator	Bullish	Neutral	Bearish
Overall Consensus	15	6	1
Technical Analysis	3	6	1
Moving Averages	12	0	0

Technical Analysis >

Similar Stocks

Stocks similar to BR:P2AT34
Company	Price & Change	Follow
BR:D2OX34Amdocs Ltd Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh
BR:E2PA34EPAM Systems, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh
BR:N1IC34NICE Ltd Unsponsored Brazilian Depositary Receipt Repr 0.04 ADR
BR:P2EG34Pegasystems Inc. Unsponsored Brazilian Depositary Receipt Repr 0.083333 Sh
BR:V2RN34Varonis Systems, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.166667 Sh

Compare BR:P2AT34 Stocks >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft

P2AT34 Stock Chart & Stats

UiPath, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A News

UiPath announces it is a launch partner for Google’s Gemini for healthcare

UiPath call volume above normal and directionally bullish

Cboe data shows mixed options sentiment in UiPath with shares down 1.18%

UiPath announces Test Cloud availability on Oracle Marketplace

Buy/Sell: Wall Street’s top 10 stock calls this week

UiPath joins NCQA AI Learning Collaborative

Midday Fly By: Boeing secures $20B Strike Fighter deal, Conagra reports Q1 beat

UiPath, Snowflake expand partnership with two-way integration

UiPath, BDO expand partnership to build agentic solution accelerators

Cboe data shows mixed options sentiment in UiPath with shares down 1.73%

UiPath Kept at Hold as Analyst Lowers Price Target to $14 Amid AI Promise but Core Growth Concerns

UiPath: Strategically Strong AI Automation Platform, But Valuation Leaves Risk‑Reward Balanced, Justifying Hold Rating

Koji Ikeda Reiterates Sell on UiPath, Keeps $15 Price Target Amid Limited Visibility on Growth Acceleration

UiPath Earns Hold Rating Despite Strong Results and Raised Guidance as Analyst Awaits Clearer AI-Driven Growth Acceleration

P2AT34 FAQ

UiPath, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A (P2AT34) Earnings & Revenues

Technical Analysis

Overall Consensus

Similar Stocks

Popular Stocks

Become an Expert with TipRanks Premium